Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7534580 PSP94 diagnostic reagents and assays

Patent 7534580 was granted and assigned to Ambrilia Biopharma, Inc. on May, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Ambrilia Biopharma, Inc.
Date Filed
June 17, 2005
Date of Patent
May 19, 2009
Patent Application Number
11154673
Patent Citations Received
‌
US Patent 12091693 PSMA binding ligand-linker conjugates and methods for using
0
‌
US Patent 11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer
0
‌
US Patent 11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7534580
Patent Primary Examiner
‌
Ann Y. Lam

Find more entities like US Patent 7534580 PSP94 diagnostic reagents and assays

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.